Volume 2, Issue 1: Frank Amato, President and CEO, and Dr. Daniel Alkon, Chief Scientific Advisor, SYNAPS Dx, Discuss First Minimally Invasive Test for Alzheimer’s Disease

Dear Colleagues,

Good news for the medical travel community, domestic and international: Medical Travel & Digital Health News (MTDHN) has been accepted as the sponsor of the first “Medical Travel Month” – January 2022 – in the Society for Healthcare Marketing and Development, American Hospital Association’s “2022 Calendar of Health Observances & Recognition Days.

MTDHN is excited to share with our readers a month full of exciting news, partnerships, blogs, and facts highlighting facilities that specialize in medical travel and tourism. If you would like to have your hospital or facility featured during Medical Travel Month, please submit a 500-word descriptor with photos for review via Dylan Matukaitis <dmatukaitis@cpronline.com>

In this issue, we speak with Frank Amato, President and CEO, and Dr. Daniel Alkon, Chief Scientific Advisor, SYNAPS Dx, to discuss the first minimally invasive test providing accurate and early diagnosis of Alzheimer’s disease.

This issue also brings you news on SYNAPS Dx completing its $10 Million Series A investment, the launch of Aster Hospitals UAE Oncology Centre in Dubai, the digital health ecosystem and voices of key healthcare leaders, surprise billing law, and more.

Please stay safe and tell me how you are breaking ground in these growing industries.

Laura Carabello
Executive Editor and Publisher
Medical Travel & Digital Health News
lcarabello@cpronline.com
https://twitter.com/MTT_eNews
https://www.facebook.com/MTT.eNews/
https://www.linkedin.com/company/medical-travel-today

Leave a Reply

Top